Percutaneous coronary intervention: Current perspective

Keio Journal of Medicine

Volumn 50, Issue 3, 2001, Pages 152-160

  Hinohara, Tomoaki ^a,b,c  

^a SEQUOIA HOSPITAL   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c Cardiovascular Medicine and Coronary Intervention   (United States)

Author keywords

Atherectomy; PCI (percutaneous coronary intervention); PTCA (percutaneous transluminal coronary angioplasty); Restenosis; Stent

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST;

ARTERY EMBOLISM; ATHERECTOMY; BRACHYTHERAPY; CORONARY ARTERY DISEASE; CORONARY STENT; HEART INFARCTION; HUMAN; POSTOPERATIVE COMPLICATION; RESTENOSIS; SHORT SURVEY; SURGICAL TECHNIQUE; THROMBOCYTE AGGREGATION; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT PLANNING;

EID: 0034765051     PISSN: 00229717     EISSN: None     Source Type: Journal    
DOI: 10.2302/kjm.50.152     Document Type: Short Survey

References (44)

1. Gruntzig AR, Senning A, Siegenthaler WE: Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 1979; 301: 61-68
2. Mullin SM, Passamani ER, Mock MB: Historical background of the National Heart, Lung and Blood Institute Registry for Percutaneous Transluminal Coronary Angioplasty. Am J Cardiol 1984; 53: 3C-6C
3. Detre K, Holubkov R, Kelsey S, Cowley M, Kent K, Williams D, Myler R, Faxon D, Holmes D Jr, Bourassa M, et al.: Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. The National Heart. Lung, and Blood Institute Registry. N Engl J Med 1988; 318: 265-270
4. Block PC, Myler RK, Stertzer S, Fallon JT: Morphology after transluminal angioplasty in human beings. N Engl J Med 1981; 305: 382-385
5. Waller BF, Gorfinkel HJ, Rogers FJ, Kent KM, Roberts WC: Early and late morphologic changes in major epicardial coronary arteries after percutaneous transluminal coronary angioplasty. Am J Cardiol 1984; 53: 42C-47C
6. Potkin BN, Roberts WC: Effects of percutaneous transluminal coronary angioplasty on atherosclerotic plaques and relation of plaque composition and arterial size to outcome. Am J Cardiol 1988; 62: 41-50
7. Lincoff AM, Popma JJ, Ellis SG, Hacker JA, Topol EJ: Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile. J Am Coll Cardiol 1992; 19: 926-935
8. Ellis SG, Roubin GS, King SB 3rd, Douglas JS Jr, Weintraub WS, Thomas RG, Cox WR: Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation 1988; 77: 372-379
9. Detre KM, Holmes DR Jr, Holubkov R, Cowley MJ, Bourassa MG, Faxon DP, Dorros GR, Bentivoglio LG, Kent KM, Myler RK: Incidence and consequences of periprocedural occlusion: The 1985 1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 1990; 82: 739-750
10. Nobuyoshi M, Kimura T, Nosaka H, Mioka S, Ueno K, Yokoi H, Hamasaki N, Horiuchi H, Ohishi H: Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol 1988; 12: 616-623
11. Schwartz L, Bourassa MG, Lesperance J, Aldridge HE, Kazim F. Salvatori VA, Henderson M, Bonan R, David PR: Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med 1988; 318: 1714-1719
12. Weintraub WS, Boccuzzi SJ, Klein JL, Kosinski AS, King SB 3rd, Ivanhoe R, Cedarholm JC, Stillabower ME, Talley JD, DeMaio SJ, et al.: Lack of effect of lovastatin on restenosis after coronary angioplasty. N Engl J Med 1994; 331: 1331-1337
13. Rowe MH, Hinohara T, White NW, Robertson GC, Selmon MR, Simpson JB: Comparison of dissection rates and angiographic results following directional coronary atherectomy and coronary angioplasty. Am J Cardiol 1990; 66: 49-53
14. Hinohara T, Rowe MH, Robertson GC, Selmon MR, Braden L, Leggett JH, Vetter JW, Simpson JB: Effect of lesion characteristics on outcome of directional coronary atherectomy. J Am Coll Cardiol 1991; 17: 1112-1120
15. Simonton CA, Leon MB, Kuntz RE, et al.: Acute and late clinical and angiographic results of directional atherectomy in the Optimal Atherectomy Restenosis Study (OARS). Circulation 1995; 92: 1-545 (Suppl)
16. Topol EJ, Leya F, Pinkerton CA, Whitlow PL, Hofling B, Simonton CA, Masden RR, Serruys PW, Leon MB, Williams DO, et al.: A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. N Engl J Med 1993; 329: 221-227
17. Baim DS, Cutlip DE, Sharma SK, Ho KK, Fortuna R, Schreiber TL, Feldman RL, Shani J, Senerchia C, Zhang Y, et al.: Final results of the Balloon vs. Optimal Atherectomy Trial (BOAT). Circulation 1998; 97: 322-331
18. Ellis SG, Popma JJ, Buchbinder M, Franco I, Leon MB, Kent KM, Richard AD, Satler LF, Topol EJ, Whitlow PL: Relation of clinical presentation, stenosis morphology, and operator technique to the procedural results of rotational atherectomy and rotational atherectomy-facilitated angioplasty. Circulation 1994; 89: 882-892
19. Reisman M, Harms V, Whitlow P, Feldman T, Fortuna R, Buchbinder M: Comparison of early and recent results with rotational atherectomy. J Am Coll Cardiol 1997; 29: 353-357
20. Dill T, Dietz U, Hamm CW, Kuchler R, Rupprecht HJ, Haude M, Cyran J, Ozbek C, Kuck KH, Berger J. et al.: A randomized comparison of balloon angioplasty versus rotational atherectomy in complex coronary lesions (COBRA study). Eur Heart J 2000; 21: 1727-1729
21. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L: Intravascular stems to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987; 316: 701-706
22. Roubin GS, Cannon AD, Agrawal SK, Macander PJ, Dean LS, Baxley WA, Breland J: Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation 1992; 85: 916-927
23. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, et al.: A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994; 331: 496-501
24. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, et al.: A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994; 331: 489-495
25. Leon MB, Baim DS, Popma JJ, Gordon PC, Cutlip DE, Ho KK, Giambartolomei A, Diver DJ, Lasorda DM, Williams DO, et al.: A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med 1998; 339: 1665-1671
26. Schomig A, Neumann FJ, Kastrati A, Schuhlen H, Blasini R, Hadamitzky M, Walter H, Zitzmann-Roth EM, Richardt G, Alt E, et al.: A randomized comparison of antiplatelet and anti-coagulant therapy alter the placement of coronary-artery stents. N Engl J Med 1996; 334: 1084-1089
27. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G, Gaglione A, Goldberg SL, Tobis JM: Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995; 91: 1676-1688
28. Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Wong C, Hong MK, Kovach JA, Leon MB: Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation 1996; 94: 35-43
29. Kimura T, Kaburagi S, Tamura T, Yokoi H, Nakagawa Y, Yokoi H, Hamasaki N, Nosaka H, Nobuyoshi M, Mintz GS, et al.: Remodeling of human coronary arteries undergoing coronary angioplasty or atherectomy. Circulation 1997; 96: 475-483
30. Teirstein PS, Massullo V, Jani S, Popma JJ, Mintz GS, Russo RJ, Schatz RA, Guarneri EM, Steuterman S, Morris NB, et al.: Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997; 336: 1697-1703
31. Leon MB, Moses JW, Lansky AJ, et al.: Intracoronary gamma radiation for the prevention of recurrent in-stent restenosis: final results from the gamma-1 trial. Circulation 1999; 100: 384 (Suppl)
32. START data presented by Popma J. at the ACC 2000
33. Raizner AE, Oesterle SN, Waksman R, Serruys PW, Colombo A, Lim YL, Yeung AC, van der Giessen WJ, Vandertie L, Chiu JK, et al.: Inhibition of restenosis with β-emitting radiotherapy. Report of the Proliferation Reduction with Vascular Energy Trial (PREVENT). Circulation 2000; 102: 951-958
34. Kim HS, Waksman R, Cottin Y, Kollum M, Bhargava B, Mehran R, Chan RC, Mintz GS: Edge stenosis and geographical miss following intracoronary gamma radiation therapy for in-stent restenosis. J Am Coll Cardiol 2001; 37: 1026-30
35. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasly. The EPIC Investigation. N Engl J Med 1994; 330: 956-961
36. Tcheng JE, Harrington RA, Kottke-Marchant K, Kleiman NS, Ellis SG, Kereiakes DJ, Mick MJ, Navetta FI, Smith JE, Worley SJ, et al.: Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrilin in elective coronary intervention. IMPACT Investigators. Circulation 1995; 91: 2151-2157
37. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. The EPILOG Investigators. N Engl J Med 1997; 336: 1689-1696
38. Lincoff AM, Tcheng JE, Califf RM, Kereiakes DJ, Kelly TA, Timmis GC, Kleiman NS, Booth JE, Balog C, Cabot CF, et al.: Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Circulation 1999; 99: 1951-1958
39. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. The EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. Lancet 1998; 352: 87-92
40. Novel dosing regimen of eptifihatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial. Lancet 2000; 356: 2037-2044
41. Baim DS: The SAFER Trial. Expert Presentation at Transcatheter Cardiovascular Therapeutics Meeting, Oct. 2000.
42. Sousa JE, Costa MA, Abizaid A, Abizaid AS, Feres F, Pinto IM, Seixas AC, Staico R, Mattos LA, Sousa AG, et al.: Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2001; 103: 192-195
43. Moussa I, Moses J, Di Mario C, Busi G, Reimers B, Kohayashi Y, Albiero R, Ferraro M, Colombo A: Stenting after optimal lesion debulking (SOLD) registry. Angiographic and clinical outcome. Circulation 1998; 98: 1604-1609
44. Hannan EL, Racz M. Ryan TJ, McCallister BD, Johnson LW, Arani DT, Guerci AD, Sosa J, Topol EJ: Coronary angioplasty volume-outcome relationships for hospitals and cardiologists. JAMA 1997; 277: 892-898